NCT01896037View on ClinicalTrials.gov

Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 28, 2017

Study Completion Date

March 28, 2017

Conditions
Spinal Cord InjuryTetraplegiaQuadraplegiaLow HDL-cHigh LDL-c
Interventions
DIETARY_SUPPLEMENT

Omega-3 supplements

Daily omega-3 supplements of 600 mg EPA (Eicosapentaenoic acid) and 300 mg DHA (Docosahexaenoic acid) for 5 months.

Trial Locations (1)

R3A 1M4

Health Sciences Centre, Winnipeg

All Listed Sponsors
collaborator

The Association of Rehabilitation Medicine in Manitoba

UNKNOWN

lead

University of Manitoba

OTHER

NCT01896037 - Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels | Biotech Hunter | Biotech Hunter